Detection of Circulating Tumor Cells

Figure 4

Kaplan-Meier plots of samples from metastatic breast (a), colon (b), and prostate (c) cancer patients with 0, 1–4, 5–24, and >25 CTC at the start of therapy. The number of patients at risk is listed at every time point of measurement.

(a)

(b)

(c)